Analysis of ECG in athletes running in mountain route conditions

The purpose of this work is to analyse changes in ECG and heart rate variability (HRV) metrics in athletes during 10 km running in mountain route conditions. Eighteen healthy athletes carrying a 12-lead ECG GE Holter recorder and a heart rate monitor ran a route with slopes similar as trail races. QRS duration, QRS area, R-wave peak, ST elevation at J-point and J+60 ms, ST slope and T-wave peak indices were computed after signal-averaging ECG segments at different sloping stages of running (S1-S6) and at a control stage (S0) before running. HRV analysis included standard time and frequency metrics: mean RR (normal, N) interval, SDNN, RMSSD, low and high frequency absolute and normalized power (LF, HF, LFn, HFn) and LF/HF ratio. QRS area and R-peak were reduced during stage 1 in lateral leads, comparing to rest before running. ST slope was significantly higher during upslope stages in leads II, V4 and V5. T-wave amplitude increased significantly in precordial leads during upload running. ST segment depressed in leads II, III and V5 respect control. Mean RR, SDNN, LF and LFn showed high significant differences (p<0.01) among stages and HF and LF/HF were also varying (p<0.05). Changes of ECG and HRV indices can help understanding the cardiac function in runners performing extreme stress.Postprint (published version

Manifold learning characterization of abnormal myocardial motion patterns: application to CRT-induced changes

International audienceThe present paper aims at quantifying the evolution of a given motion pattern under cardiac resynchronization therapy (CRT). It builds upon techniques for population-based cardiac motion quantifica-tion (statistical atlases, for inter-sequence spatiotemporal alignment and the definition of normal/abnormal motion). Manifold learning is used on spatiotemporal maps of myocardial motion abnormalities to represent a given abnormal pattern and to compare any individual to that pattern. The methodology was applied to 2D echocardiographic sequences in a 4-chamber view from 108 subjects (21 healthy volunteers and 87 CRT candidates) at baseline, with pacing ON, and at 12 months follow-up. Experiments confirmed that recovery of a normal motion pattern is a necessary but not su cient condition for CRT response

Atlas-Based Quantification of Myocardial Motion Abnormalities: Added-Value for Understanding the Effect of Cardiac Resynchronization Therapy

International audienc

Atlas-based Quantification of Myocardial Motion Abnormalities: Added-value for the Understanding of CRT Outcome?

International audienceIn this paper, we present the use of atlas-based indexes of abnormality for the quantification of cardiac resynchronization therapy (CRT) outcome in terms of motion. We build an atlas of normal motion from 21 healthy volunteers to which we compare 88 CRT candidates before and after the therapy. Abnormal motion is quantified locally in time and space using a statistical distance to normality, and changes induced by the therapy are related with clinical measurements of CRT outcome. Results correlate with recent clinical hypothesis about CRT response, namely that the correction of specific mechanisms responsible for cardiac dyssynchrony conditions the response to the therapy

Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation:AXAFA biomolecule study

Aims: Different disease processes can combine to cause atrial fibrillation (AF). Their contribution to recurrent AF after ablation in patients is not known. Cardiovascular processes associated with recurrent AF after AF ablation were determined by quantifying biomolecules related to inflammation, metabolism, proliferation, fibrosis, shear stress, atrial pressure, and others in the AXAFA biomolecule study.Methods and results: Twelve circulating cardiovascular biomolecules (ANGPT2, BMP10, CA125, hsCRP, ESM1, FABP3, FGF23, GDF15, IGFBP7, IL6, NT-proBNP, and hsTnT) were quantified in plasma samples obtained prior to a first AF ablation using high-throughput, high-precision assays. Cox regression was used to identify biomolecules associated with recurrent AF during the first 3 months after AF ablation. In 433 patients (64 years [58, 70]; 33% women), baseline concentrations of ANGPT2, BMP10, hsCRP, FGF23, FABP3, GDF15, and NT-proBNP were elevated in patients with recurrent AF (120/433; 28%). After adjustment for 11 clinical features and randomized treatment, elevated NT-proBNP [hazard ratio (HR) 1.58, 95% confidence interval (1.29, 1.94)], ANGPT2 [HR 1.37, (1.12, 1.67)], and BMP10 [HR 1.24 (1.02, 1.51)] remained associated with recurrent AF. Concentrations of ANGPT2, BMP10, and NT-proBNP decreased in patients who remained arrhythmia free, but not in patients with recurrent AF, highlighting their connection to AF. The other eight biomarkers showed unchanged concentrations. Conclusion: Elevated concentrations of ANGPT2, BMP10, and NT-proBNP are associated with recurrent AF after a first AF ablation, suggesting that processes linked to disturbed cardiomyocyte metabolism, altered atrial shear stress, and increased load contribute to AF after AF ablation in patients

Catheter Ablation of Atrial Fibrillation in Patients with Previous Lobectomy or Partial Lung Resection: Long-Term Results of an International Multicenter Study.

INTRODUCTION Data regarding the efficacy of catheter ablation in patients with atrial fibrillation (AF) and patients' previous history of pulmonary lobectomy/pneumonectomy are scanty. We sought to evaluate the efficacy and long-term follow-up of catheter ablation in this highly selected group of patients. MATERIAL AND METHODS Twenty consecutive patients (8 females, 40%; median age 65.2 years old) with a history of pneumonectomy/lobectomy and paroxysmal or persistent AF, treated by means of pulmonary vein isolation (PVI) at ten participating centers were included. Procedural success, intra-procedural complications, and AF recurrences were considered. RESULTS Fifteen patients had a previous lobectomy and five patients had a complete pneumonectomy. A large proportion (65%) of PV stumps were electrically active and represented a source of firing in 20% of cases. PVI was performed by radiofrequency ablation in 13 patients (65%) and by cryoablation in the remaining 7 cases. Over a median follow up of 29.7 months, a total of 7 (33%) AF recurrences were recorded with neither a difference between patients treated with cryoablation or radiofrequency ablation or between the two genders. CONCLUSIONS Catheter ablation by radiofrequency ablation or cryoablation in patients with pulmonary stumps is feasible and safe. Long-term outcomes are favorable, and a similar efficacy of catheter ablation has been noticed in both males and females